"As Central Florida's premier center for healing, hope and discovery, Lakeland Regional Health's state-of-the-art Hollis Cancer Center campus offers all the services necessary for patients to conquer cancer and is designed expressly with those in our care in mind."

During the past decade, Lakeland Regional Cancer Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 57 clinical trials were completed, i.e. on average, 190% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 27 clinical trials were completed. i.e. 675% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lakeland Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored and "Eastern Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lakeland Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Lakeland Regional Cancer Center" are "Breast Cancer" (21 trials), "Prostate Cancer" (9 trials), "Colorectal Cancer" (6 trials), "Recurrent Melanoma" (6 trials) and "Stage IIIC Cutaneous Melanoma AJCC v7" (5 trials). Many other conditions were trialed in "Lakeland Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Lakeland Regional Cancer Center" are "Drug" (96 trials), "Other" (44 trials), "Biological" (35 trials), "Procedure" (16 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (15 trials), "Docetaxel" (11 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Lakeland Regional Cancer Center" are 84 trials for "All" genders, 29 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Lakeland Regional Cancer Center". undefined are not yet recruiting, 7 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Lakeland Regional Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Lakeland Regional Cancer Center, 3 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".